申请人:ICI Pharma
公开号:US04463173A1
公开(公告)日:1984-07-31
A compound of the formula I: ##STR1## in which R.sup.1 is any C-3 substituent from antibacterially-active cephalosporins; R.sup.2 is any C-4 substituent from antibacterially-active cephalosporins; R.sup.3 is H, hydroxy, amino, 1-6C alkyl, 1-6C alkanoyl, 1-6C alkoxy, 1-6C alkanoylamino or 1-6C alkylamino, phenyl(1-6C)-alkyl or phenyl, each optionally substituted by methoxy; ##STR2## is of the formula II or III: ##STR3## in which R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 may have a variety of values, e.g. hydrogen, carboxy, cyano or alkyl; and the salts thereof. Manufacturing processes, pharmaceutical compositions and a method of treating a bacterial infection are also disclosed.
公式I的化合物:##STR1##,其中R.sup.1是来自具有抗菌活性的头孢菌素的任何C-3取代基;R.sup.2是来自具有抗菌活性的头孢菌素的任何C-4取代基;R.sup.3是H、羟基、氨基、1-6C烷基、1-6C醇酰基、1-6C烷氧基、1-6C醇酰胺基或1-6C烷基胺基、苯基(1-6C)-烷基或苯基,每个基可选择地被甲氧基取代;##STR2##是公式II或III:##STR3##,其中R.sup.4、R.sup.5、R.sup.6、R.sup.7、R.sup.8和R.sup.9可以有多种取值,例如氢、羧基、氰基或烷基;及其盐。还公开了制造过程、药物组合物和治疗细菌感染的方法。